The Georgia Chapter of The Leukemia & Lymphoma Society (LLS), the world’s largest non-profit health organization dedicated to finding cures and ensuring access to treatments for all blood cancer patients, has announced that the SACK Company has joined LLS’s 2019 Statesboro Light The Night as the presenting sponsor.
Light The Night, an annual fundraising event, will take place at 7:30 p.m. Saturday at the RAC on campus at Georgia Southern University. This is the inaugural event for Statesboro.
Light The Night is a fundraising campaign benefiting LLS and their funding of research to find blood cancer cures. Coming together for a common goal, friends, family and co-workers form fundraising walk teams.
Millions of consumers also help by donating at retail outlets. Culminating in inspiration and memorable evening walks every fall, participants in 140 communities across North America join together carrying illuminated lanterns to take steps to end cancer – white for survivors, red for supporters and gold in memory of loved ones lost to cancer.
“We’re thrilled to have SACK Company as a sponsor for our first ever Statesboro Light The Night,” said Lauren Mathews, campaign manager at The Leukemia & Lymphoma Society. “We appreciate their generosity and are grateful for their commitment to help make this year’s Light The Night the best yet. We are taking steps to end cancer.”
Statesboro blood cancer survivors Raina Chance and Katherine Welch serve on the committee and are very involved in launching the event here in Statesboro.
"Without research and the funding that The Leukemia & Lymphoma Society provides, I would not be here today sharing my story with my community," Welch said. "We owe a special thanks to our presenting sponsor, SACK Company; community sponsors, BBWH Insurers (and) SunCatcher Shutters & Blinds; and route sponsors, Statesboro Real Estate/PMG Rentals, Wise Choice Realty and more."
LLS was founded by a family for families, beginning 70 years ago at a time when a diagnosis of leukemia was nearly 100% fatal. Now, with the development of new treatments for childhood leukemia, to today’s advances in precision medicine and immunotherapy, LLS has had a colossal impact on advancing cancer cures and changing the way cancer is treated and the care for patients.
Through its efforts, it has invested nearly $1.3 billion in cutting-edge research to advance therapies. Thanks to research, survival rates for patients with many blood cancers have doubled, tripled and even quadrupled since the early 1960s. Yet, despite these advances, about one third of patients with blood cancer still do not survive even five years after their diagnosis.
To form a team or to learn more, call the LLS office at (912) 436-3274 or visit www.lightthenight.org/events/Statesboro.